title: Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study Group.
authors.affiliation: Department of Vascular and Transplant Surgery, University of Arkansas, USA.
authors.forename: G
authors.initials: G
authors.lastname: Barone
authors.forename: C M
authors.initials: CM
authors.lastname: Bunke
authors.forename: M G
authors.initials: MG
authors.lastname: Choc
authors.forename: D E
authors.initials: DE
authors.lastname: Hricik
authors.forename: J H
authors.initials: JH
authors.lastname: Jin
authors.forename: J B
authors.initials: JB
authors.lastname: Klein
authors.forename: C L
authors.initials: CL
authors.lastname: Marsh
authors.forename: D I
authors.initials: DI
authors.lastname: Min
authors.forename: M D
authors.initials: MD
authors.lastname: Pescovitz
authors.forename: R
authors.initials: R
authors.lastname: Pollak
authors.forename: T L
authors.initials: TL
authors.lastname: Pruett
authors.forename: J B
authors.initials: JB
authors.lastname: Stinson
authors.forename: J S
authors.initials: JS
authors.lastname: Thompson
authors.forename: E
authors.initials: E
authors.lastname: Vasquez
authors.forename: T
authors.initials: T
authors.lastname: Waid
authors.forename: D G
authors.initials: DG
authors.lastname: Wombolt
authors.forename: R L
authors.initials: RL
authors.lastname: Wong
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001794:Blood Pressure; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects*; D004311:Double-Blind Method; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine